跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rhinisaph-10 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rhinisaph-10
Approved
STANDARD
Rhinisaph-10
Enicar Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
68db569cf6004060
Company
Enicar Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
68db569cf6004060
Drug Approval Philippines Name
Rhinisaph-10
Product Name
Rhinisaph-10
Registration Number
DRP-9425
Brand Name
Rhinisaph-10
Generic Name
Cetirizine Dihydrochloride
Dosage Form
Oral solution (Oral Drops)
Dosage Strength
10mg/mL
Manufacturer
Enicar Pharmaceuticals Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
29 December 2020
Expiry Date
29 December 2025
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
68db569cf6004060
Type
Standard
Back to Philippines FDA Approvals